AGM/EGMJun 9, 2026, 06:07 AM
CervoMed Stockholders Elect Directors, Approve Auditor & Equity Plan
AI Summary
CervoMed Inc. held its 2026 Annual Meeting of Stockholders on June 8, 2026, with a quorum of 67.2% of outstanding shares. Stockholders elected eight directors, ratified RSM US LLP as the independent auditor for 2026, and approved, on an advisory basis, the compensation of named executive officers for 2024. Additionally, Amendment No. 1 to the 2025 Equity Incentive Plan was approved.
Key Highlights
- Eight directors were elected to serve until the next Annual Meeting.
- RSM US LLP was ratified as the independent auditor for 2026 with 6,092,751 votes For.
- Advisory approval of named executive officer compensation for 2024 received 3,073,013 votes For.
- Amendment No. 1 to the 2025 Equity Incentive Plan was approved with 3,044,744 votes For.
- A quorum of 6,218,593 shares, representing 67.2% of outstanding shares, was present.
Price Impact
More from CRVO